Y R B M van Gestel
Overview
Explore the profile of Y R B M van Gestel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuiper J, van Herk-Sukel M, van Gestel Y, Voogd A, Lemmens V, Siesling S
Value Health
. 2016 May;
17(7):A663.
PMID: 27202415
No abstract available.
2.
Razenberg L, van Gestel Y, de Hingh I, Loosveld O, Vreugdenhil G, Beerepoot L, et al.
BMC Cancer
. 2016 Feb;
16:110.
PMID: 26882902
Background: Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in...
3.
Bakens M, van Gestel Y, Bongers M, Besselink M, Dejong C, Molenaar I, et al.
Br J Surg
. 2015 Oct;
102(13):1670-5.
PMID: 26437024
Background: Surgical resection for pancreatic cancer offers the only chance of cure. Assessment of the resectability of a pancreatic tumour is therefore of great importance. The aim of the study...
4.
Bos A, van Erning F, van Gestel Y, Creemers G, Punt C, van Oijen M, et al.
Eur J Cancer
. 2015 Sep;
51(17):2553-61.
PMID: 26360411
Background: Currently available data suggest that delaying the start of adjuvant chemotherapy in colon cancer patients has a detrimental effect on survival. We analysed which factors impact on the timing...
5.
Speelman A, van Gestel Y, Rutten H, de Hingh I, Lemmens V
Br J Surg
. 2015 Jun;
102(9):1114-22.
PMID: 26069100
Background: Many developments in medicine are likely to have influenced the treatment of gastrointestinal cancer, including rates of resection. This study sought to investigate changes in surgical resection rates over...
6.
Razenberg L, van Gestel Y, Creemers G, Verwaal V, Lemmens V, de Hingh I
Eur J Surg Oncol
. 2015 Feb;
41(4):466-71.
PMID: 25680955
Background: Population-based data on the percentage of colorectal cancer (CRC) patients with synchronous peritoneal carcinomatosis (PC) being treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are currently lacking....
7.
Thomassen I, van Gestel Y, Aalbers A, van Oudheusden T, Wegdam J, Lemmens V, et al.
Eur J Surg Oncol
. 2014 Feb;
40(5):511-514.
PMID: 24534364
Background: During resection of a colorectal tumor a careful inspection of the abdomen should be performed to detect metastases. The aim of the current study was to compare the proportions...
8.
van Gestel Y, Thomassen I, Lemmens V, Pruijt J, van Herk-Sukel M, Rutten H, et al.
Eur J Surg Oncol
. 2013 Nov;
40(8):963-9.
PMID: 24183168
Introduction: Population-based data on metachronous peritoneal carcinomatosis (PC) after curative resection of colorectal origin are scarce. The aim of this study was to investigate the incidence of and risk factors...
9.
van Gestel Y, Rutten H, de Hingh I, van den Broek E, Nieuwenhuijzen G, Coebergh J, et al.
Neth J Med
. 2013 Jun;
71(4):209-14.
PMID: 23723118
Background: The standardised mortality ratio (SMR) for rectal or anal cancer was above average in a large tertiary referral centre for locally advanced rectal cancer in the Netherlands. The aim...
10.
Hoogwegt M, Hoeks S, Pedersen S, Scholte Op Reimer W, van Gestel Y, Verhagen H, et al.
Eur J Vasc Endovasc Surg
. 2010 Jun;
40(3):355-62.
PMID: 20580273
Objectives: Smoking is an important modifiable risk factor in patients with peripheral arterial disease (PAD). We investigated differences in quality of life (QoL) between patients who quitted smoking during follow-up...